Selected article for: "cc international license and infection number"
Author: Mengying Dong; Xiaojun Cao; Mingbiao Liang; Lijuan Li; Huiying Liang; Guangjian Liu
Title: Understand Research Hotspots Surrounding COVID-19 and Other Coronavirus Infections Using Topic Modeling
  • Document date: 2020_3_30
    • ID: 3wuh6k6g_39
    Snippet: This work suggests that research needs to be focused on pathogenesis, therapeutics, virus diagnostics, vaccines and viral genomics for COVID-19, which could then necessitate nationallevel support for ongoing research, if required. Pathogenesis research is usually important but time-consuming. We believe such studies will be available in the future. The more important and urgent topic is therapeutics research, which accounts for only 9.68% in COVI.....
    Document: This work suggests that research needs to be focused on pathogenesis, therapeutics, virus diagnostics, vaccines and viral genomics for COVID-19, which could then necessitate nationallevel support for ongoing research, if required. Pathogenesis research is usually important but time-consuming. We believe such studies will be available in the future. The more important and urgent topic is therapeutics research, which accounts for only 9.68% in COVID-19 research, much lower than 18.88% in other CoV infections research. With the number of infection cases increasing rapidly, therapeutics research will be more and more urgently needed. In addition, virus diagnostics, vaccines and viral genomics show small proportions in all CoV infections research, but even smaller in the field of COVID-19. This shows how little we know about CoVs. It is time . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC ND International license and CoV infection research: 1
    • cc NC ND International license and infection case: 1, 2, 3, 4, 5, 6
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and ongoing research: 1, 2
    • cc NC ND International license and pathogenesis research: 1
    • cc NC ND International license and rapidly increase: 1, 2
    • cc NC ND International license and small proportion: 1, 2, 3
    • CoV infection and infection case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CoV infection and infection case number: 1, 2
    • CoV infection and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CoV infection and ongoing research: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CoV infection and pathogenesis research: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CoV infection and rapidly increase: 1, 2, 3, 4, 5
    • CoV infection and small proportion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • CoV infection research and infection case: 1, 2
    • CoV infection research and International license: 1
    • CoV infection research and ongoing research: 1, 2, 3, 4
    • CoV infection research and pathogenesis research: 1, 2
    • infection case and small proportion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10